Home|Journals|Articles by Year

Directory for Medical Articles
 

Original Article



Pharmacokinetics of a new imidazoline receptor agonist in rat plasma after intragastric and intravenous administration

Kulikov Aleksandr, Avtina Tatyana, Pokrovsky Mikhail, Korokin Mikhail.


Abstract

3-(1h-benzimidazol-2-yl)-1,2,2- trimethylcyclopentancarboxylic acid (C7070) is a novel synthetic imidazoline receptor agonist - potential antidiabetic agent. This study aimed to obtain the pharmacokinetic profiles in rats. Additionally, an HPLC MS/MS method was developed and validated to quantify C7070 in rat plasma. The pharmacokinetic profiles of intragastric and intravenous administration routes at singles doses of 50 mg/kg, were studied in rats. The elimination half-life of intravenously administered C7070 was approximately 154,1 min. The maximum plasma level of C7070 was reached approximately 170 min (2,8 h) after intragastric administration, with a Cmax value of 17,6 μg/mL and an AUC (o-t) value of 6964 μg*min-1/mL; the oral bioavailability was approximately 18%.

Key words: New antidiabetic agent; HPLC MS/MS; Pharmacokinetics; Imidazoline receptor agonist; C7070; Rat.






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net







Do you want to use OJS for your journal ?
work with an experienced partner
www.OJSHosting.net

eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.